Hubei, China

Jiquan Ou

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Wuhan Healthgen Biotechnology Corp.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiquan Ou. Retrieved from https://idiyas.com/inventor/jiquan-ou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jiquan Ou: Advancements in Biopharmaceutical Excipients

Introduction

Jiquan Ou is an innovative inventor based in Hubei, China, known for his significant contributions to the field of biopharmaceuticals. With a focus on high-purity recombinant human serum albumin, Ou has developed methods that are set to enhance drug formulations and ensure safer clinical applications. His passion for innovation is reflected in the two patents he has secured, showcasing his commitment to advancing medical science.

Latest Patents

Jiquan Ou's most recent patents include:

1. **Preparation method and application of high-purity plant-derived recombinant human serum albumin**: This invention outlines a novel method for preparing high-purity recombinant human serum albumin (OsrHSA), which can effectively replace plasma-derived human serum albumin. The patent emphasizes the compound's safety and efficacy in clinical settings and as a pharmaceutical excipient, while also maintaining the biological activity of biological macromolecules.

2. **Chromatographic method for isolating and purifying high-purity recombined human serum albumin**: This patent describes an intricate chromatographic method to isolate and purify recombinant human serum albumin. The process includes cation-exchange chromatography and the strategic use of alcohol to remove endotoxins, ultimately achieving a product with a purity greater than 99.9999% that meets the standards set by the Chinese pharmacopoeia.

Career Highlights

Jiquan Ou is associated with Wuhan Healthgen Biotechnology Corporation, where he collaborates with other prominent researchers in the field. His work focuses on developing high-quality biopharmaceutical products, demonstrating his dedication to innovation and healthcare improvement. The patents he has secured reflect his significant contributions to enhancing the safety and efficiency of drug delivery systems.

Collaborations

Throughout his career, Ou has worked alongside notable scientists such as Daichang Yang and Bo Shi. Collaborations with such esteemed colleagues have further propelled his research forward and supported the creation of groundbreaking methodologies in the purification and application of recombinant proteins.

Conclusion

Jiquan Ou’s innovative work in the field of biopharmaceuticals stands out for its potential to transform how human serum albumin is utilized in clinical applications. With two patents that articulate novel methods and applications, Ou is paving the way for safer and more effective biopharmaceutical products, making significant strides in medical science. His contributions will undoubtedly influence future research and healthcare practices, exemplifying the extraordinary impact of dedicated inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…